长征五号乙运载火箭

Search documents
25天9次发射!中国商业航天冲刺“中国版星链”
第一财经· 2025-08-21 05:19
2025.08. 21 本文字数:3673,阅读时长大约6分钟 作者 | 第一财 经 乔心怡、郑星语 中国的商业航天迎来了密集发射期。 第一财经记者梳理发现,过去25天内,我国进行了九次火箭发射。根据泰伯智库发布的2025上半年 中国商业航天产业进展数据年报,截至六月,我国完成35次火箭发射任务。这意味着,过去25天 内,我国火箭的发射次数已经超过了上半年火箭发射次数的四分之一。 在过去九次的发射中,有至少五次发射服务于国网星座(GW星座),这个由中国卫星网络集团主导 建设的宽带互联网卫星项目,被视为"中国版星链"。和SpaceX星链类似,国网星座也需要通过大规 模组网来实现全球覆盖。 | | | | 中国近期航天发射情况统计(7.27-8.21) | | | | --- | --- | --- | --- | --- | --- | | 日期 | 发射火箭 | 一箭几星 | 火箭研发单位 | 项目 | 卫星 | | 8月19日 | 力箭一号遥十运载火箭 ·中国妇女号 | 一箭七星 | 中科宇航 | 中科卫星星座 (中科卫星05星) | 中科卫星05星,多功能试验二号卫星01星、02星、03星 (天拓六号卫星 ...
产业观察:商业航天跟踪13期,长征五号乙运载火箭发射成功,中国星网加速组网
GUOTAI HAITONG SECURITIES· 2025-08-20 14:11
Group 1: Launch Successes - The Long March 5B rocket successfully launched the low Earth orbit satellite internet group 08 on August 13, 2025, marking the 588th launch of the Long March series[1] - In the past two weeks, China Star Network has accelerated its satellite deployment with four successful launches (groups 05-08) of low Earth orbit satellites[1] Group 2: Upcoming Launches and Developments - The Gushenxing II rocket series has completed key ground tests and is entering countdown for its maiden flight, set to carry over 1 ton of payload including six commercial satellites and two non-separable payloads[1] - Three rocket companies, Blue Arrow Aerospace, Tianbing Technology, and CAS Space, have been shortlisted for the "One Rocket, 18 Satellites" tender by Yuanxin Satellite, with service delivery expected by March 2026[4] Group 3: Regulatory Changes and Financing - On August 13, 2025, President Trump signed an executive order to ease regulations on the U.S. commercial space industry, aiming to enhance competitiveness and streamline approval processes for new space activities[4] - Aerospace company Yuhang Yuxing completed a C+ round financing of 430 million yuan, aimed at developing satellite internet infrastructure[23] - Beijing Weiguang Qihang Technology completed an angel round financing of several million yuan, focusing on carbon fiber composite rocket development[23] Group 4: Market Performance - The Wind Commercial Aerospace Index (8841877.WI) fell by 0.64% during the week of August 11-15, 2025, with a trading volume of 189 billion yuan, down 3.93% from the previous week[4] - Among the 66 companies in the commercial aerospace sector, 24.24% saw their stock prices rise, with top gainers including Feilihua (30.81%) and Aerospace Science and Technology (16.93%)[4]
智通港股早知道 | 终端设备直连卫星服务管理规定发布 蔚来-SW(09866)4月交付2.39万辆同比增长53%
Zhi Tong Cai Jing· 2025-05-01 23:47
Group 1 - The National Internet Information Office and six other departments have jointly issued the "Regulations on the Management of Direct Satellite Services for Terminal Equipment," effective from June 1, 2025, which governs the provision and use of direct satellite services within China [1] - China's low-orbit satellite constellation, Qianfan, has successfully completed five batches of satellite launches, with over 600 satellites ordered, amounting to approximately 4.5 billion RMB, and plans to deliver over 200 satellites by 2025 [1] Group 2 - MGM China reported total revenue of 7.994 billion HKD for Q1 2025, a decrease of 3.2% year-on-year, with adjusted EBITDA of 2.368 billion HKD, down 5.46% [6] - China Hongqiao reported a net profit of 6.357 billion RMB for Q1 2025, representing a year-on-year increase of 46.46%, with total revenue of 40.173 billion RMB, up 15.56% [10] Group 3 - NIO delivered 23,900 vehicles in April, a year-on-year increase of 53%, while Li Auto delivered 33,939 vehicles, up 31.6% [7] - BYD's total sales of new energy vehicles reached approximately 1.3809 million units in the first four months of 2025, reflecting a year-on-year growth of 46.98% [7] Group 4 - Xinda Biopharmaceuticals reported total product revenue exceeding 2.4 billion RMB in Q1 2025, maintaining a strong year-on-year growth of over 40%, with four new drugs launched during the quarter [9] - Hansoh Pharmaceutical's HS-20089 has been approved as a breakthrough therapy for platinum-resistant recurrent epithelial ovarian cancer by the National Medical Products Administration [8]